Growing community of inventors

Neuilly sur Seine, France

David Saadoun

Average Co-Inventor Count = 7.00

ph-index = 3

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 36

David SaadounDavid Klatzmann (5 patents)David SaadounEliane Piaggio (5 patents)David SaadounPatrice Cacoub (5 patents)David SaadounGilbert Bensimon (5 patents)David SaadounClaude Bernard (5 patents)David SaadounMichèle Rosenzwajg (4 patents)David SaadounMichéle Rosenzwajg (1 patent)David SaadounMichele Rosenzwajg (1 patent)David SaadounClaude Bernard (1 patent)David SaadounDavid Saadoun (5 patents)David KlatzmannDavid Klatzmann (34 patents)Eliane PiaggioEliane Piaggio (14 patents)Patrice CacoubPatrice Cacoub (7 patents)Gilbert BensimonGilbert Bensimon (5 patents)Claude BernardClaude Bernard (5 patents)Michèle RosenzwajgMichèle Rosenzwajg (5 patents)Michéle RosenzwajgMichéle Rosenzwajg (1 patent)Michele RosenzwajgMichele Rosenzwajg (1 patent)Claude BernardClaude Bernard (2 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Assistance Publique-hopitaux De Paris (5 from 318 patents)

2. Institut National De La Sante Et De La Recherche Medicale (4 from 1,743 patents)

3. Sorbonne Université (4 from 237 patents)

4. Université Pierre Et Marie Curie (paris 6) (1 from 155 patents)

5. Inserm (institut National De La Sante Et De La Recherche Medicale) (1 from 38 patents)

6. Université Pierre Et Marie Curie (67 patents)

7. Inserm (0 patent)


5 patents:

1. 12491232 - Low dose IL-2 for treating autoimmune-related or inflammatory disorders

2. 11559566 - Use of low dose IL-2 for treating autoimmune-related or inflammatory disorders

3. 10765723 - Use of low dose IL-2 for treating autoimmune—related or inflammatory disorders

4. 10293028 - Use of low dose IL-2 for treating autoimmune related or inflammatory disorders

5. 9669071 - Method for stimulating T lymphocytes with IL-2

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/25/2025
Loading…